Biological Implants Market By Origin (Autografts, Allografts, Xenografts), By Application (Cardiovascular, Orthopedic, Soft Tissue, Dental, Opthalmic, Urologic) And Segment Forecasts To 2020
Technological advancements coupled with R&D initiatives in healthcare services have led to the development of biological implants developed from cultures of pre existing cell samples. They are either purely biological in nature, comprising implantable ex situ cultured tissue or are a hybrid of cell culture combined with bio-materials such as polymers, titanium or gold alloys.
For More Information on " Biological Implants Market Research Reports" visit
-
http://www.grandviewresearch.com/industry-analysis/biological-
implants-market
The compositions of the implants depend upon the specific regenerative capacity, immunogenicity or biomechanical strength required to treat the damaged organ or tissue.Soft tissue, cardiovascular, dental, orthopedic, dental, urologic and ophthalmic implants are the application areas of biological implants market. Segmentation on the basis of origin divides them into autografts (implant material extracted from the same individual), allografts (implant material extracted from different individual of the same species) and xenograft (implant material extracted from other species, mainly bovine or porcine in nature).
The largest segment is occupied by the cardiovascular implants owing to the fact that allograft heart valve and artery/vein reconstructions have met with significant success in reducing implant rejection rates and increase post surgical survival rates.North America emerged as the most revenue contributing region due to the growing prevalence of diseases which require intervention procedures using biological implants combined with the advancements of healthcare technologies in the region. Asia Pacific is expected to grow at a lucrative CAGR for the estimated period. Presence of high unmet medical needs coupled with favorable government initiatives is major driver contributing for its growth. The key players analyzed in the report include Aastrom Biosciences Inc., IOP Inc., Maxigen Biotech Inc., CryoLife Inc., Pioneer Surgical Technologies, LifeCell Corporation, NuVasive Inc., Integra Lifescience Corporation, Edwards LifeSciences Corporation, Pegasus Biologics Inc., Stryker Corporation,
Allergan Inc., Arthro-Kinetics Plc, Tutogen Medical Inc., Asterand Plc, BioTissue Technologies AG and CR Bard Inc.
Request TOC of “Biological Implants Market Research Reports" visit http://www.grandviewresearch.com/industry-analysis/biological-implantsmarket/request-toc
About Grand View Research Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, the company offers market intelligence studies ensuring relevant and fact-based research across a range of industries including technology, chemicals, materials, healthcare and energy.
Contact: Sherry James Corporate Sales Specialist, U.S.A. Grand View Research, Inc. United States Phone: 1-415-349-0058 Toll Free: 1-888-202-9519 Email: sales@grandviewresearch.com Website: Grand View Research Blog Site: http://marketshare.blog.com/